Deferred Tax Assets, Valuation Allowance of Beta Bionics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Beta Bionics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Beta Bionics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $75,307,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Beta Bionics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $75,307,000 +$14,284,000 +23% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $61,023,000 +$9,120,000 +18% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $51,903,000 31 Dec 2023 10-K/A 28 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.